Home/News & Studies/NAD+-Sirtuin Signaling: A Potential Strategy Against Male Reproductive Aging
LongevityAnti-agingNADSirtuineReproduktives Altern AI-analyzed

NAD+-Sirtuin Signaling: A Potential Strategy Against Male Reproductive Aging

This review explores the role of the NAD+-Sirtuin axis in male reproductive aging, detailing how its dysregulation contributes to declines in testosterone, spermatogenesis, and fertility. It examines potential interventions, including NAD+ precursors and Sirtuin activators, as promising therapeutic strategies.

7 min read0 ViewsMarch 23, 2026
NAD+-Sirtuin Signaling: A Potential Strategy Against Male Reproductive Aging

Introduction

A recent review published in the World Journal of Men's Health investigates the role of the nicotinamide adenine dinucleotide (NAD+)-Sirtuin signaling pathway in male reproductive aging. This research synthesizes current evidence to propose that restoring this pathway could offer a novel approach to combat age-related declines in male fertility and reproductive function.

The Study in Detail

The review, authored by Zhou L, Lan X, Wang M, et al., and published online ahead of print in the World Journal of Men's Health (DOI: 10.5534/wjmh.250248), systematically examines the multi-system dysfunction underlying male reproductive aging. It highlights the NAD+-Sirtuin axis as a central regulator of testicular homeostasis, which becomes dysregulated with age.

Key findings detailed in the review include:

  • NAD+ Depletion and Sirtuin Inactivity: Age-related decline in NAD+ levels impairs essential cellular processes such as energy metabolism (glycolysis/TCA cycle), antioxidant defenses, and steroidogenesis. Reduced activity of Sirtuins (specifically SIRT1, SIRT3, and SIRT6) disrupts spermatogonial stem cell maintenance, the integrity of the blood-testis barrier (BTB), epigenetic programming, and immune privilege within the testes.
  • Pathological Features: The review identifies several pathological hallmarks of male reproductive aging linked to this dysregulation:
    • Structural compromise, including lysosomal dysfunction in Sertoli cells and BTB disruption.
    • Metabolic and oxidative stress, characterized by lipid accumulation, mitochondrial failure, and excessive reactive oxygen species production.
    • Chronic inflammation, evidenced by NLRP3 inflammasome activation and T-cell infiltration.
    • Epigenetic dysregulation, involving aberrant histone acetylation and imbalances in non-coding RNAs.
    • Disorders in hormonal synthesis.
  • Interventional Strategies: The authors discuss interventions targeting the NAD+-Sirtuin axis. Preclinical studies have shown promise with:
    • NAD+ precursors: Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) have been shown to restore sperm quality (e.g., +40% normality with NMN) and testosterone synthesis.
    • Sirtuin activators: Compounds like resveratrol and quercetin have demonstrated efficacy, with resveratrol reducing sperm DNA fragmentation by 45% through SIRT3 activation.
    • Lifestyle strategies: Intermittent fasting and exercise are also noted for their potential benefits.
  • Clinical Data and Gaps: While some clinical data suggest improved physiological parameters (e.g., muscle function, biological age) with NMN supplementation, the review emphasizes critical knowledge gaps. These include the need for further research on tissue-specific Sirtuin functions, the long-term safety of NAD+ boosters, and the development of individualized intervention protocols. Future research priorities include testicular-targeted delivery systems, NAD+-based biomarkers, and randomized controlled trials.

Assessment

This comprehensive review effectively consolidates existing knowledge on the NAD+-Sirtuin pathway's critical role in male reproductive health and aging. Its strength lies in synthesizing complex mechanistic details with potential therapeutic applications. By outlining the various pathological features associated with NAD+ and Sirtuin dysregulation, the authors provide a clear framework for understanding the multifaceted nature of male reproductive aging.

However, as the authors themselves acknowledge, the evidence for human applications remains largely preclinical or based on indirect clinical observations. The long-term safety and efficacy of NAD+ boosters and Sirtuin activators in humans, specifically for male reproductive aging, require extensive investigation through rigorous randomized controlled trials. The review also highlights the complexity of Sirtuin functions, noting that tissue-specific roles are not yet fully understood, which could impact the targeting of interventions.

Practical Relevance

For daily life, this review suggests that maintaining optimal NAD+ levels and Sirtuin activity could be beneficial for male reproductive health, particularly as men age. While direct clinical recommendations are still premature, the findings point towards potential strategies that might support reproductive longevity. These include:

  • Nutritional Considerations: While not explicitly detailed in the abstract, a balanced diet rich in NAD+ precursors (e.g., foods containing B vitamins) and Sirtuin activators (e.g., polyphenols found in berries, grapes, and green tea) could theoretically support these pathways.
  • Lifestyle Choices: The mention of intermittent fasting and exercise as beneficial lifestyle strategies aligns with broader health recommendations for aging and metabolic health, suggesting these practices may also indirectly support reproductive function by influencing NAD+ and Sirtuin activity.
  • Future Therapeutic Potential: For individuals concerned about age-related male infertility, this research opens avenues for future therapeutic developments. However, it is crucial to await further clinical validation before considering supplementation with NAD+ precursors or Sirtuin activators specifically for reproductive health.

Conclusion

The review underscores the NAD+-Sirtuin signaling pathway as a fundamental regulator of male reproductive health, whose age-related decline contributes significantly to male infertility. While preclinical data show promise for interventions targeting this axis, further robust clinical research is essential to establish safe and effective strategies for combating male reproductive aging in humans. This area represents a promising frontier for future therapeutic development.

Source

The world journal of men's health